Kashiv BioSciences Secures $150 Million Debt Financing from GoldenTree Asset Management
Kashiv BioSciences, LLC ("Kashiv BioSciences" or the "Company"), a fully integrated biopharmaceutical company, today ...
Hosted on MSN2mon
Kashiv Biosciences’ Phase I trial of KSHB002 injection meets primary endpoints
US-based biopharmaceutical company Kashiv Biosciences has reported that a Phase I trial of its 125mg/mL pre-filled syringe injection, KSHB002, has achieved its primary endpoints. In the trial ...
Yahoo Finance1mon
Kashiv BioSciences, LLC Obtains Marketing Authorization for Pegfilgrastim Injection from Health Canada
PISCATAWAY, N.J., February 25, 2025--(BUSINESS WIRE)--Kashiv BioSciences, LLC ("Kashiv" or the "Company") today announced that Health Canada has granted marketing authorization for its Pegfilgrastim ...
The Bakersfield Californian13d
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing ...
REYKJAVIK, Iceland, PISCATAWAY, N.J. and LONDON, March 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar me ...